Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Bayer warns of Monsanto/Syngenta deal consequences

Bayer CropScience has reportedly warned that a takeover of Syngenta by Monsanto would require a strategic review including of cross-licensing deals from it and other major R&D-based companies in the sector. Bloomberg has reported comments from Bayer CropScience chief executive office Lian Condon: “There’s only six research and development-based players in this industry so if the two biggest were to go together, inevitably it would force others to review their strategies.” Monsanto has seen its second bid for the company rejected on price grounds and regulatory concerns over competition issues. Any potential acquisition may interfere with deals among companies on product research and marketing, the Bayer CEO cautions. “There’s an awful lot of cross-licensing,” he told the newswire. “So companies would need to review what that means for the interdependencies as well.”



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts